FEATURES OF PAPILLOMAVIRUS INFECTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN
Abstract
Aim. To determine prevalence and features of human papillomavirus (HPV) infection in human immunodeficiency virus (HIV)-infected women.Materials and Methods. We recruited 150 imprisoned women aged 25 to 59 years (mean age 37.3 ± 8.0) following clinical examination and analysis of medical documentation including HIV status. Identification of high-risk HPV strains (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) was carried out using real-time polymerase chain reaction. Results. High-risk HPV strains, particularly HPV-16, -39, and -52, were detected in 58.2% of HIV-infected and 23% of HIV-negative women (p < 0.001). Furthermore, the combination of ≥ 4 HPV genotypes was more prevalent in HIV-infected women (p = 0.043). Strikingly, HIV-infected women with shorter duration of HIV-infection and/or taking antiretroviral treatment were less frequently infected with high-risk HPV (p < 0.05).Conclusions. A significant proportion of HIV-positive women is infected with HPV-16, -39, -52, or combination of ≥ 4 HPV strains.
About the Authors
KRISTINA V. Marochko
Kemerovo State Medical University
Russian Federation
Russian Federation
NATALIA V. Artymuk
Kemerovo State Medical University
Russian Federation
Russian Federation
References
1. Белокриницкая Т.Е., Фролова Н.И., Тарбаева Д.А., Глотова Е.Ю., Золотарёва А.А., Мальцева Т.В. Ассоциации генитальных инфекций и вируса папилломы человека как конфаундинг-факторы цервикальной интраэпителиальной неоплазии // Доктор.Ру. 2015. s2 (12). С.14-17.
2. Марочко К.В., Артымук Н.В. Возможности интерферонотерапии в лечении женщин, инфицированных вирусом папилломы человека высокого онкогенного риска // Мать и дитя в Кузбассе. 2017. № 1. С. 28-33.
3. Maiman M, Fruchter RG, Serur E, Remy JC, Feuer G, Boyce J. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol. 1990; 38(3): 377-382.
4. Дианова Т.В., Свердлова Е.С. Комплексное лечение предраковых заболеваний шейки матки у ВИЧ-инфицированных женщин // Онкология репродуктивных органов: от профилактики и раннего вы-явления к эффективному лечению: материалы I Нац. конгр. Москва, 2016. С. 70-71.
5. Латышева И.Б., Воронин Е.Е. ВИЧ-инфекция у женщин в РФ // Актуальные вопросы ВИЧ-инфекции: материалы междунар. науч.-практ. конф. Санкт-Петербург, 2016 г. С. 9-12.
6. Ладная Н.Н., Покровский В.В., Дементьева Л.А., Симашев Т.И., Липина Е.С., Юрин О.Г. Развитие эпидемии ВИЧ-инфекции в Российской Федерации в 2015 г. // Актуальные вопросы ВИЧ-инфекции : материалы между-нар. науч.-практ. конф., Санкт-Петербург, 2016 г. С. 4-9.
7. Mbulawa ZZ, Coetzee D, Williamson AL. Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status. BMC Infect Dis. 2015; (15): 459.
8. Theiler RN, Farr SL, Karon JM, Paramsothy P, Viscidi R, Duerr A, et al. High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol. 2010; 115(6): 1150-1158.
9. Papasavvas E, Surrey LF, Glencross DK, Azzoni L, Joseph J, Omar T, et al. High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women. Oncoimmunology. 2016; 5(5): e1128612.
10. Houlihan CF, Larke NL, Watson-Jones D, Smith-McCune KK, Shiboski S, Gravitt PE, et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS. 2012; 26 (17): 2211-2222.
11. Rositch AF, Gravitt PE, Smith JS. Growing evidence that HPV infection is associated with an increase in HIV acquisition: exploring the issue of HPV vaccination. Sex Transm Infect. 2013; 89(5): 357.
12. Venkatajothi R, VinodKumar CS. Human papillomavirus infection in women with the human immunodeficiency virus type-1. Int J Biol Med Res. 2011; 2(3): 771-774.
13. Mitchell SM, Pedersen HN, Eng Stime E, Sekikubo M, Moses E, Mwesigwa D, et al. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity. BMC Womens Health. 2017; 17(1): 4.
14. Dartell M, Rasch V, Kahesa C., Mwaiselage J, Ngoma T, Junge J, et al. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study. Sex Transm Dis. 2012; 39(3): 201-208.
15. Menon S, Wusiman A, Boily MC, Kariisa M, Mabeya H, Luchters S, et al. Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis. PLoS One. 2016; 11 (10): e0163965.
16. Veldhuijzen NJ, Braunstein SL, Vyankandondera J, Ingabire C, Ntirushwa J, Kestelyn E, et al. The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. BMC Infect Dis. 2011; 11(1): 333.
17. Thunga S, Andrews A, Ramapuram J, Satyamoorthy K, Kini H, Unnikrishnan В, et al. Cervical cytological abnormalities and human papilloma virus infection in women infected with HIV in Southern India. J Obstet Gynaecol Res. 2016; 42(12): 1822-1828.
18. Артымук Н.В., Марочко К.В. Эффективность выявления вируса папилломы человека при помощи устройства для самостоятельного забора вагинального отделяемого // Акушерство и гинекология. 2016. № 3. С. 85-91.
19. Марочко К.В. Чувствительность методов исследования в выявлении цервикальной интраэпителиальной неоплазии 3 степени и рака шейки матки // Фундаментальная и клиническая медицина. 2016. № 2. С.51-55.
20. Whitham HK, Hawes SE, Chu H, Oakes JM, Lifson AR, Kiviat NB, et al. A Comparison of the Natural History of HPV Infection and Cervical Abnormalities among HIV-Positive and HIV-Negative Women in Senegal, Africa. Cancer Epidemiol Biomarkers Prev. 2017; 26(6): 886-894.
21. Shrestha S, Sudenga SL, Smith JS, Bachmann LH, Wilson CM, Kempf MC. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents. BMC Infectious Diseases. 2010; 10(1): 295.
22. Konopnicki D, Manigart Y, Gilles C, Barlow P, de Marchin J, Feoli F, et al. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV- positive women. J Infect Dis. 2013; 207(11): 1723-1729.
23. Kang M, Cu-Uvin S. Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy. HIV Med. 2012; 13 (6): 372-378.
24. Papasavvas E, Surrey LF, Glencross DK, Azzoni L, Joseph J, Omar T, et al. High-risk oncogenic HPV genotype infection associates with increased immune activation and T cell exhaustion in ART-suppressed HIV-1-infected women. Oncoimmunology. 2016; 5 (5): e1128612.
Review
For citations:
Marochko K.V., Artymuk N.V. FEATURES OF PAPILLOMAVIRUS INFECTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN. Fundamental and Clinical Medicine. 2017;2(3):35-41. (In Russ.)
Views:
597
Email this article 